Variation in blood levels of hormones in obese patients following weight reduction induced by endoscopic and surgical bariatric therapies

Cytokine

Volumn 77, Issue , 2016, Pages 56-62

  Wroblewski, Eugeniusz ^a   Swidnicka Siergiejko, Agnieszka ^a   Hady, Hady Razak ^a   Luba, Magdalena ^a   Konopko, Marzena ^a   Kurek, Krzysztof ^a   Dadan, Jacek ^a   Dabrowski, Andrzej ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Adipokines; Bariatric surgery; Gastric balloon; Obesity; Weight loss

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; GHRELIN; HORMONE; LEPTIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN; UNCLASSIFIED DRUG; ADIPOQ PROTEIN, HUMAN; CYTOKINE; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN;

ADULT; ARTICLE; BARIATRIC SURGERY; BODY MASS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOSCOPIC SURGERY; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT FAILURE; WEIGHT REDUCTION; BLOOD; ENDOSCOPY; MIDDLE AGED; PROCEDURES; TIME FACTOR; TREATMENT OUTCOME;

ADIPONECTIN; ADULT; BARIATRIC SURGERY; CYTOKINES; ENDOSCOPY; FEMALE; GHRELIN; GPI-LINKED PROTEINS; HORMONES; HUMANS; LECTINS; LEPTIN; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OBESITY; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; WEIGHT LOSS;

EID: 84946218883     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.10.013     Document Type: Article

References (33)

1. Acosta A., Abu Dayyeh B.K., Port J.D., Camilleri M. Recent advanced in clinical practice challenges and opportunities in the management of obesity. Gut 2014, 63:687-695.
2. Tilg H., Moschen A.R. Mechanism behind the link between obesity and gastrointestinal cancers. Best Pract. Res. Clin. Gastroenterol. 2014, 28:599-610.
3. Ouchi N., Parker J.L., Lugus J.J., Walsh K. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011, 11:85-97.
4. Nigro E., Scudiero O., Monaco M.L., Palmieri A., Mazzarella G., Costagliola C., Bianco A., Daniele A. New insight into adiponectin role in obesity and obesity-related diseases. Biomed. Res. Int. 2014, 2014:658913.
5. Münzberg H., Morrison C.D. Structure, production and signaling of leptin. Metabolism 2015, 64:13-23.
6. Al-Suhaimi E.A., Shehzad A. Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunity. Eur. J. Med. Res. 2013, 18:12.
7. Auguet T., Quintero Y., Riesco D., Morancho B., Terra X., Crescenti A., Broch M., Aguilar C., Olona M., Porras J.A., Hernandez M., Sabench F., del Castillo D., Richart C. New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women. BMC Med. Genet. 2011, 12:60.
8. Verhulst P.J., Depoortere I. Ghrelin's second life: from appetite stimulator to glucose regulator. World J. Gastroenterol. 2012, 18:3183-3195.
9. Goktas Z., Moustaid-Moussa N., Shen C.L., Boylan M., Mo H., Wang S. Effects of bariatric surgery on adipokine-induced inflammation and insulin resistance. Front. Endocrinol. (Lausanne) 2013, 10(4):69.
10. Arismendi E., Rivas E., Agustí A., Ríos J., Barreiro E., Vidal J., Rodriguez-Roisin R. The systemic inflammome of severe obesity before and after bariatric surgery. PLoS ONE 2014, 9:e107859.
11. Gumbau V., Bruna M., Canelles E., Guaita M., Mulas C., Basés C., Celma I., Puche J., Marcaida G., Oviedo M., Vázquez A. A prospective study on inflammatory parameters in obese patients after sleeve gastrectomy. Obes. Surg. 2014, 24:903-908.
12. Hady H.R., Dadan J., Luba M. The influence of laparoscopic sleeve gastrectomy on metabolic syndrome parameters in obese patients in own material. Obes. Surg. 2012, 22:13-22.
13. Hady H.R., Dadan J., Gołaszewski P. 100 obese patients after laparoscopic adjustable gastric banding - the influence on BMI, ghrelin and insulin concentration, parameters of lipid balance and co-morbidities. Adv. Med. Sci. 2012, 57:58-64.
14. Botella-Carretero J.I., Luque-Ramírez M., Alvarez-Blasco F., Peromingo R., San Millán J.L., Escobar-Morreale H.F. The increase in serum visfatin after bariatric surgery in morbidly obese women is modulated by weight loss, waist circumference, and presence or absence of diabetes before surgery. Obes. Surg. 2008, 18:1000-1006.
15. Hosseinzadeh-Attar M.J., Golpaie A., Janani L., Derakhshanian H. Effect of weight reduction following bariatric surgery on serum visfatin and adiponectin levels in morbidly obese subjects. Obes. Facts 2013, 6:193-202.
16. Siejka A., Jankiewicz-Wika J., Kołomecki K., Cywiński J., Piestrzeniewicz K., Swietosławski J., Stepień H., Komorowski J. Long-term impact of vertical banded gastroplasty (VBG) on plasma concentration of leptin, soluble leptin receptor, ghrelin, omentin-1, obestatin, and retinol binding protein 4 (RBP4) in patients with severe obesity. Cytokine 2013, 64:490-493.
17. Urbanová M., Dostálová I., Trachta P., Drápalová J., Kaválková P., Haluzíková D., Matoulek M., Lacinová Z., Mráz M., Kasalický M., Haluzík M. Serum concentrations and subcutaneous adipose tissue mRNA expression of omentin in morbid obesity and type 2 diabetes mellitus: the effect of very-low-calorie diet, physical activity and laparoscopic sleeve gastrectomy. Physiol. Res. 2014, 63:207-218.
18. Konopko-Zubrzycka M., Baniukiewicz A., Wróblewski E., Kowalska I., Zarzycki W., Górska M., Dabrowski A. The effect of intragastric balloon on plasma ghrelin, leptin, and adiponectin levels in patients with morbid obesity. J. Clin. Endocrinol. Metab. 2009, 94:1644-1649.
19. Nikolic M., Boban M., Ljubicic N., Supanc V., Mirosevic G., Pezo Nikolic B., Krpan R., Posavec L., Zjacic-Rotkvic V., Bekavac-Beslin M., Gacina P. Morbidly obese are ghrelin and leptin hyporesponders with lesser intragastric balloon treatment efficiency: ghrelin and leptin changes in relation to obesity treatment. Obes. Surg. 2011, 21:1597-1604.
20. Szczepaniak J.P., Owens M.L., Shukla H., Perglos J., Garner W. Comparability of weight loss reporting after gastric bypass and sleeve gastrectomy using BOLD Data 2008-2011. Obes. Surg. 2015, 25:788-795.
21. Reinhold R. Critical analysis of long-term weight loss following gastric bypass. Surg. Gynecol. Obstet. 1982, 155:385-394.
22. Himpes J., Dobbeleir J., Peeters G. Long-term results of laparoscopic sleeve gastrectomy for obesity. Ann. Surg. 2010, 252:319-324.
23. Van de Laar A., de Caluwe L. Relative outcome measures for bariatric surgery. Evidence against excess weight loss and excess body mass index loss from a series of laparoscopic Roux-en-Y gastric bypass patients. Obes. Surg. 2011, 21:763-767.
24. Taskoforce A.S.G.E. A pathway to endoscopic bariatric therapies. Gastrointest. Endosc. 2011, 74:943-953.
25. Derosa G., Fogari E., D'Angelo A., Bianchi L., Bonaventura A., Romano D., Maffioli P. Adipocytokine levels in obese and non-obese subjects: an observational study. Inflammation 2013, 36:914-920.
26. Zhang Z., Wang F., Wang B.J., Chu G., Cao Q., Sun B.G., et al. Inhibition of leptin-induced vascular extracellular matrix remodeling by adiponectin. J. Mol. Endocrinol. 2014, 53:145-154.
27. Moschen A.R., Kaser A., Enrich B., Mosheimer B., Theurl M., Niederegger H., et al. Visfatin, an adipocytokine with proinflammatory and immunomodulating properties. J. Immunol. 2007, 178:1748-1758.
28. Moreno-Navarrete J.M., Catalán V., Ortega F., Gómez-Ambrosi J., Ricart W., Frühbeck G., Fernández-Real J.M. Circulating omentin concentration increases after weight loss. Nutr. Metab. (Lond.) 2010, 7:27.
29. Yamawaki H., Kuramoto J., Kameshima S., Usui T., Okada M., Hara Y. Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells. Biochem. Biophys. Res. Commun. 2011, 408:339-343.
30. Compher C., Badellino K.O. Obesity and inflammation: lessons from bariatric surgery. JPEN J. Parenter. Enteral Nutr. 2008, 32:645-647.
31. Swidnicka-Siergiejko A., Wróblewski E., Dabrowski A. Endoscopic treatment of obesity. Can. J. Gastroenterol. 2011, 25:627-633.
32. Milone L., Strong V., Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or =50). Obes. Surg. 2005, 15:612-617.
33. Bradley D., Conte C., Mittendorfer B., Eagon J.C., Varela J.E., Fabbrini E., Gastaldelli A., Chambers K.T., Su X., Okunade A., Patterson B.W., Klein S. Gastric bypass and banding equally improve insulin sensitivity and β cell function. J. Clin. Invest. 2012, 122:4667-4674.